CDMOs bring a wealth of experience to various areas of drug development, including process development, analytical testing, and quality control. This expertise, combined with a focus on innovation, can help drug developers overcome technical challenges and optimize their development programs.

Crucially, CDMOs also provide pharmaceutical companies with various manufacturing capabilities, from small-scale clinical trials to large-scale commercial production. This flexibility allows developers to focus on their core competencies while relying on CDMOs to provide the necessary infrastructure and support for drug manufacturing. Where strong technical expertise is required, CDMOs play a vital role in advancing pharmaceutical innovation through the implementation of phase-appropriate technology transfer.

This white paper explores the various types of technology transfer from preclinical to commercial stages and proposes strategies to successfully foster innovation.

To access the white paper, kindly complete the form below.